Clinical Trial Update: Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing nifekalant to amiodarone for new-onset atrial fibrillation after cardiac surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Postoperative Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)
• Nifekalant (nifekalant)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: New Onset Atrial Fibrillation, Complications; Cardiac, Postoperative | Phase 3 | Status: RECRUITING